Skip to main content
. Author manuscript; available in PMC: 2008 Apr 7.
Published in final edited form as: Eur J Endocrinol. 2005 Oct;153(4):551–563. doi: 10.1530/eje.1.01987

Figure 1.

Figure 1

Expression of noradrenaline transporter mRNA (A) and protein (B) in phaeochromocytomas from patients with MEN 2 and VHL syndrome. Levels of noradrenaline transporter mRNA in tumours from ten patients with VHL syndrome and ten patients with MEN 2 (mean±s.e.m.), were determined by quantitative PCR, with expression shown relative to that of β-actin mRNA, as described in the Materials and methods section. Noradrenaline transporter protein in the Western blot is shown by the 79 kDa bands in five tumours from both groups. **Significantly (P < 0.002) higher expression in MEN 2 than VHL tumours.